Option Care Health, Inc. (NASDAQ:OPCH) Receives Average Rating of “Moderate Buy” from Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has been assigned a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, four have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $30.5385.

Several brokerages have issued reports on OPCH. Zacks Research downgraded shares of Option Care Health from a “hold” rating to a “strong sell” rating in a research note on Monday, May 11th. Weiss Ratings cut shares of Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price target for the company. in a research report on Friday, May 1st. Stephens set a $30.00 target price on shares of Option Care Health in a research report on Friday, May 1st. Finally, JPMorgan Chase & Co. decreased their price target on Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a research note on Monday, May 4th.

Insiders Place Their Bets

In other news, CEO John Charles Rademacher purchased 12,500 shares of the stock in a transaction on Monday, May 4th. The stock was bought at an average price of $21.18 per share, with a total value of $264,750.00. Following the transaction, the chief executive officer owned 695,152 shares in the company, valued at $14,723,319.36. The trade was a 1.83% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Timothy P. Sullivan bought 24,154 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The stock was purchased at an average price of $20.69 per share, for a total transaction of $499,746.26. Following the transaction, the director owned 73,383 shares of the company’s stock, valued at $1,518,294.27. The trade was a 49.06% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders bought 73,264 shares of company stock valued at $1,548,316. 1.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Option Care Health

Hedge funds have recently bought and sold shares of the stock. Durable Capital Partners LP boosted its holdings in Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after buying an additional 4,720,988 shares in the last quarter. Fuller & Thaler Asset Management Inc. grew its holdings in shares of Option Care Health by 12.1% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company’s stock worth $221,707,000 after buying an additional 752,058 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in Option Care Health by 6.2% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company’s stock valued at $135,355,000 after acquiring an additional 247,118 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Option Care Health by 0.9% during the first quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock worth $104,368,000 after buying an additional 36,208 shares in the last quarter. Finally, Southpoint Capital Advisors LP raised its holdings in shares of Option Care Health by 20.0% during the 1st quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock worth $96,912,000 after acquiring an additional 600,000 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Trading Up 0.3%

Shares of OPCH stock opened at $21.04 on Friday. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The stock’s 50 day simple moving average is $21.92 and its two-hundred day simple moving average is $28.39. The company has a market cap of $3.30 billion, a PE ratio of 16.31, a price-to-earnings-growth ratio of 1.17 and a beta of 0.65.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company’s quarterly revenue was up 1.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Research analysts predict that Option Care Health will post 1.64 earnings per share for the current year.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.